Cabaletta Bio, Inc.
CABA
$1.21
$0.054.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 85.70% | -1.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.24% | 9.14% | |||
| Operating Income | -2.24% | -9.14% | |||
| Income Before Tax | -6.39% | -10.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.39% | -10.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.39% | -10.97% | |||
| EBIT | -2.24% | -9.14% | |||
| EBITDA | -2.13% | -9.28% | |||
| EPS Basic | -4.99% | -10.91% | |||
| Normalized Basic EPS | -4.99% | -10.92% | |||
| EPS Diluted | -4.84% | -10.71% | |||
| Normalized Diluted EPS | -4.99% | -10.92% | |||
| Average Basic Shares Outstanding | 1.34% | 0.05% | |||
| Average Diluted Shares Outstanding | 1.34% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||